We are live on ! Find out more
Simplex Trading

Simplex Trading Portfolio holdings

AUM $149B
1-Year Est. Return 62.07%
 

Simplex Trading, founded in 2004 and headquartered in Chicago, Illinois, is a technology-driven proprietary trading firm specializing in market-making and liquidity provision, primarily in U.S. equity options and futures options. Leveraging advanced proprietary software and data-driven analysis, the firm optimizes trading strategies and develops innovative solutions to capitalize on financial market opportunities, maintaining a competitive edge through automation and a collaborative team of technologists and traders. With a workforce exceeding 300 and led by CEO Erik Swanson since 2014, Simplex operates with a low-ego, high-intelligence culture, focusing on minimal bureaucracy and rapid execution, while also making strategic venture capital investments in fintech startups. Recognized as a top workplace in Chicago by Built In’s 2025 awards, Simplex continues to evolve, blending cutting-edge technology with a commitment to market efficiency and growth.

This Fund
S&P 500
This Quarter Est. Return
-17.92%
1 Year Est. Return
+62.07%
3 Year Est. Return
+116.86%
5 Year Est. Return
+116.02%
10 Year Est. Return
+774.44%
AUM
$94.1B
AUM Growth
-$15.3B
Cap. Flow
+$11.3B
Cap. Flow %
12.02%
Top 10 Hldgs %
40.12%
Holding
11,810
New
1,405
Increased
4,027
Reduced
4,289
Closed
1,792

Sector Composition

Rank Sector Weight
1 Technology 0.84%
2 Communication Services 0.32%
3 Consumer Discretionary 0.32%
4 Financials 0.28%
5 Healthcare 0.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MODN
9451
PUT
DELISTED
MODEL N, INC.
MODN
$2K ﹤0.01%
100
-1,400
-93% -$34.9K
GRTX
9452
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$2K ﹤0.01%
1,729
-16,834
-91% -$28.8K
AFIB
9453
CALL
DELISTED
Acutus Medical Inc
AFIB
$2K ﹤0.01%
1,900
+700
+58% +$601
GMDA
9454
CALL
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$2K ﹤0.01%
1,500
-7,900
-84% -$20.1K
BCEL
9455
CALL
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$2K ﹤0.01%
1,500
+100
+7% +$209
BTTX
9456
PUT
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$2K ﹤0.01%
+1,400
New +$2.34K
XBTF
9457
PUT
DELISTED
VanEck Bitcoin Strategy ETF
XBTF
$2K ﹤0.01%
100
-1,400
-93% -$44.2K
NMRD
9458
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$2K ﹤0.01%
992
-177
-15% -$567
PCTI
9459
DELISTED
PCTEL, Inc. Common Stock
PCTI
$2K ﹤0.01%
691
-741
-52% -$3.13K
PCTI
9460
PUT
DELISTED
PCTEL, Inc. Common Stock
PCTI
$2K ﹤0.01%
500
-300
-38% -$1.27K
ARCE
9461
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$2K ﹤0.01%
137
-69
-33% -$1.21K
PYR
9462
PUT
DELISTED
PyroGenesis Canada Inc. Common Shares
PYR
$2K ﹤0.01%
1,100
-1,700
-61% -$3.62K
RVLP
9463
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$2K ﹤0.01%
+1,598
New +$2.31K
PRTK
9464
PUT
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2K ﹤0.01%
+1,500
New +$3.27K
SNLN
9465
DELISTED
Highland/iBoxx Senior Loan ETF
SNLN
$2K ﹤0.01%
+196
New +$2.99K
NMTR
9466
PUT
DELISTED
9 Meters Biopharma
NMTR
$2K ﹤0.01%
530
-630
-54% -$5.94K
IMBI
9467
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$2K ﹤0.01%
1,696
-8,521
-83% -$24.3K
IMBI
9468
PUT
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$2K ﹤0.01%
2,000
-8,600
-81% -$24.6K
NYMX
9469
DELISTED
Nymox Pharmaceutical Corp
NYMX
$2K ﹤0.01%
5,103
-4,523
-47% -$4.16K
RXDX
9470
CALL
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$2K ﹤0.01%
100
-3,300
-97% -$95.6K
APTO
9471
DELISTED
Aptose Biosciences, Inc.
APTO
$2K ﹤0.01%
9
-4
-31% -$1.91K
AUD
9472
DELISTED
Audacy, Inc.
AUD
$2K ﹤0.01%
2,607
-14,162
-84% -$28.4K
SJR
9473
DELISTED
Shaw Communications Inc.
SJR
$2K ﹤0.01%
+100
New +$2.89K
LYLT
9474
CALL
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$2K ﹤0.01%
+600
New +$6.42K
CAJ
9475
PUT
DELISTED
Canon, Inc.
CAJ
$2K ﹤0.01%
100
-1,400
-93% -$33.8K

Similar funds

Simplex Trading's Q2 2022 Portfolio in Review

As of Q2 2022, Simplex Trading held 11,810 positions worth $94.1B, down 14% from $109B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Simplex Trading deployed $11.3B of net new capital in Q2 2022, opening 1,405 new positions and adding to 4,027 existing holdings. Its largest new stake was Alphabet (Google) Class C: 543,540 shares worth $59.4M.

By sector, the portfolio is most concentrated in Technology at 0.84% of assets, up from 0.67% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was United Airlines, an estimated $22.7M trimmed.

  • Simplex Trading's largest Q2 2022 buy was Alphabet (Google) Class C: 543,540 shares worth $59.4M.
  • Simplex Trading added most to Apple in Q2 2022, an estimated $286M increase.
  • Simplex Trading's biggest Q2 2022 reduction was United Airlines, cutting an estimated $22.7M.
  • Simplex Trading fully exited State Street SPDR S&P 500 ETF Trust in Q2 2022, selling an estimated $51.5M.
  • Simplex Trading's ten largest holdings make up 40% of its $94.1B portfolio in Q2 2022.
  • Simplex Trading opened 1,405 new positions and closed 1,792 in Q2 2022.
  • Simplex Trading's portfolio value fell 14% quarter-over-quarter to $94.1B.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.